This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...
Brand plans are often of limited value due to a weak development process, insufficient market insights, and...
In this new position paper, we propose a proven and straightforward methodology to help the management of...